| Product Code: ETC12463534 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Taiwan Imatinib Drug Market Overview |
3.1 Taiwan Country Macro Economic Indicators |
3.2 Taiwan Imatinib Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Taiwan Imatinib Drug Market - Industry Life Cycle |
3.4 Taiwan Imatinib Drug Market - Porter's Five Forces |
3.5 Taiwan Imatinib Drug Market Revenues & Volume Share, By Drug Form, 2021 & 2031F |
3.6 Taiwan Imatinib Drug Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Taiwan Imatinib Drug Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Taiwan Imatinib Drug Market Revenues & Volume Share, By Sales Channel, 2021 & 2031F |
3.9 Taiwan Imatinib Drug Market Revenues & Volume Share, By Mode of Administration, 2021 & 2031F |
4 Taiwan Imatinib Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic myeloid leukemia (CML) in Taiwan |
4.2.2 Growing awareness about targeted cancer therapies among healthcare professionals and patients |
4.2.3 Favorable government regulations supporting access to innovative cancer treatments |
4.3 Market Restraints |
4.3.1 High cost of imatinib therapy leading to affordability issues for some patients |
4.3.2 Stringent regulatory requirements for drug approval and market entry |
4.3.3 Competition from generic imatinib drugs impacting market share of branded products |
5 Taiwan Imatinib Drug Market Trends |
6 Taiwan Imatinib Drug Market, By Types |
6.1 Taiwan Imatinib Drug Market, By Drug Form |
6.1.1 Overview and Analysis |
6.1.2 Taiwan Imatinib Drug Market Revenues & Volume, By Drug Form, 2021 - 2031F |
6.1.3 Taiwan Imatinib Drug Market Revenues & Volume, By Tablets, 2021 - 2031F |
6.1.4 Taiwan Imatinib Drug Market Revenues & Volume, By Capsules, 2021 - 2031F |
6.1.5 Taiwan Imatinib Drug Market Revenues & Volume, By Powder Form, 2021 - 2031F |
6.1.6 Taiwan Imatinib Drug Market Revenues & Volume, By Liquid Form, 2021 - 2031F |
6.1.7 Taiwan Imatinib Drug Market Revenues & Volume, By Extended Release Tablets, 2021 - 2031F |
6.2 Taiwan Imatinib Drug Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Taiwan Imatinib Drug Market Revenues & Volume, By Leukemia Treatment, 2021 - 2031F |
6.2.3 Taiwan Imatinib Drug Market Revenues & Volume, By Gastrointestinal Stromal Tumors, 2021 - 2031F |
6.2.4 Taiwan Imatinib Drug Market Revenues & Volume, By Chronic Myeloid Leukemia, 2021 - 2031F |
6.2.5 Taiwan Imatinib Drug Market Revenues & Volume, By Breast Cancer Treatment, 2021 - 2031F |
6.2.6 Taiwan Imatinib Drug Market Revenues & Volume, By Rare Tumor Management, 2021 - 2031F |
6.3 Taiwan Imatinib Drug Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Taiwan Imatinib Drug Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Taiwan Imatinib Drug Market Revenues & Volume, By Cancer Research Centers, 2021 - 2031F |
6.3.4 Taiwan Imatinib Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.3.5 Taiwan Imatinib Drug Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.3.6 Taiwan Imatinib Drug Market Revenues & Volume, By Government Healthcare Units, 2021 - 2031F |
6.4 Taiwan Imatinib Drug Market, By Sales Channel |
6.4.1 Overview and Analysis |
6.4.2 Taiwan Imatinib Drug Market Revenues & Volume, By Direct Procurement, 2021 - 2031F |
6.4.3 Taiwan Imatinib Drug Market Revenues & Volume, By Distributors, 2021 - 2031F |
6.4.4 Taiwan Imatinib Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Taiwan Imatinib Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.6 Taiwan Imatinib Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.5 Taiwan Imatinib Drug Market, By Mode of Administration |
6.5.1 Overview and Analysis |
6.5.2 Taiwan Imatinib Drug Market Revenues & Volume, By Oral Administration, 2021 - 2031F |
6.5.3 Taiwan Imatinib Drug Market Revenues & Volume, By Injection Therapy, 2021 - 2031F |
6.5.4 Taiwan Imatinib Drug Market Revenues & Volume, By Infusion Therapy, 2021 - 2031F |
6.5.5 Taiwan Imatinib Drug Market Revenues & Volume, By Combination Therapy, 2021 - 2031F |
6.5.6 Taiwan Imatinib Drug Market Revenues & Volume, By Targeted Therapy, 2021 - 2031F |
7 Taiwan Imatinib Drug Market Import-Export Trade Statistics |
7.1 Taiwan Imatinib Drug Market Export to Major Countries |
7.2 Taiwan Imatinib Drug Market Imports from Major Countries |
8 Taiwan Imatinib Drug Market Key Performance Indicators |
8.1 Patient adherence rate to imatinib therapy |
8.2 Number of healthcare providers trained in prescribing and monitoring imatinib treatment |
8.3 Rate of new CML diagnoses in Taiwan |
9 Taiwan Imatinib Drug Market - Opportunity Assessment |
9.1 Taiwan Imatinib Drug Market Opportunity Assessment, By Drug Form, 2021 & 2031F |
9.2 Taiwan Imatinib Drug Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Taiwan Imatinib Drug Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Taiwan Imatinib Drug Market Opportunity Assessment, By Sales Channel, 2021 & 2031F |
9.5 Taiwan Imatinib Drug Market Opportunity Assessment, By Mode of Administration, 2021 & 2031F |
10 Taiwan Imatinib Drug Market - Competitive Landscape |
10.1 Taiwan Imatinib Drug Market Revenue Share, By Companies, 2024 |
10.2 Taiwan Imatinib Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here